Company: BIAF
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010787
Chunk: 13

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 7
Chunk 13
---
10-Q, is collected, recorded, processed, summarized, and reported within the time periods specified in the rules of the
SEC. The Company’s disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated
to management to allow timely decisions regarding required disclosure. As of March 31, 2025, the end of the period covered by this Quarterly
Report, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of our “disclosure controls and procedures,”
as defined in Rule 13a-15(e) under the Exchange Act. The Chief Executive Officer and Chief Financial Officer assessed the effectiveness
of our disclosure controls and procedures as of March 31, 2025. Based on their assessment, they have concluded that as of March 31, 2025,
our disclosure controls and procedures are effective.

Changes in Internal Control over Financial Reporting

There were no changes in our internal controls (as
defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) over financial reporting during the three months ended March 31, 2025,
the period covered by this Quarterly Report, that could materially affect, or are reasonably likely to materially affect, our internal
control over financial reporting.

23

PART II

ITEM 1. LEGAL PROCEEDINGS.

From time to time, we are involved in various disputes
and litigation matters that arise in the ordinary course of business. To date, we have had no material pending legal proceedings, and
we are not engaged in any legal proceedings that are expected, individually or in the aggregate, to have a material adverse impact on
our financial position or results of operations.

ITEM 1A. RISK FACTORS.

In addition to other information set forth in this
Quarterly Report, you should carefully consider the “Risk Factors” discussed in the 2024 Form 10-K for a discussion of important
factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements
contained in this Quarterly Report. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial
might materially adversely affect our actual business, financial condition, and operating results. The following information updates and
should be read in conjunction with the information disclosed in Part I, Item 1A, “Risk Factors,” contained in our 2024 Form
10-K. Except as disclosed below, there have been no material changes from the risk factors disclosed